Data di Pubblicazione:
2023
Abstract:
Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the treatment of hepatocellular carcinoma, but the actual treatment is usually discussed by a multidisciplinary tumor board in a personalized manner, leading to potential treatment differences based on Western and Eastern perspectives. The aim of this paper is to integrate literature evidence with the eminent experiences collected during a focused session at the Mediterranean Interventional Oncology (MIO) Live Congress 2023.
Tipologia CRIS:
03B-Review in Rivista / Rassegna della Lett. in Riv. / Nota Critica
Keywords:
ablation; chemoembolization; hepatocellular carcinoma; interventional oncology; locoregional treatments; radioembolization
Elenco autori:
Iezzi R.; Posa A.; Contegiacomo A.; Lee I.J.; Bale R.; Tanzilli A.; Tenore L.; Giuliante F.; Gasbarrini A.; Goldberg S.N.; Jakobs T.; Pompili M.; Bargellini I.; Sala E.; Kim H.-C.
Link alla scheda completa:
Pubblicato in: